Navigation Links
US Oncology Wins Three National Safety Council Awards
Date:3/30/2009

Texas Chapter Recognizes Pharmaceutical Distribution Center, Specialty Pharmacy and Research Network

HOUSTON, March 30 /PRNewswire/ -- Three US Oncology, Inc. businesses have received a Safety Excellence Perfect Record Award in the Occupational Safety & Health category from the Texas chapter of the National Safety Council: US Oncology Research, OncologyRx Care Advantage(TM), and US Oncology Specialty, LP. This is the third time US Oncology companies have received the Occupational Excellence Award from the national organization's Texas chapter. More information can be found at www.usoncology.com.

The award is presented to companies, units and/or facilities that have completed a period of at least 12 consecutive months without incurring an occupational injury or illness that resulted in days away from work or death.

From 2007 to 2008, US Oncology Specialty, OncologyRx Care Advantage, and US Oncology Research each achieved a zero percent incidence rate for number of days away from work. Following are the 2008 statistics for each:

  • US Oncology Specialty, LP - 34 employees who worked 63,628 hours
  • OncologyRx Care Advantage--25 employees working 47,765 hours
  • US Oncology Research Network--16 employees who worked 29,989 hours

Formed in 1999, US Oncology collaborates with providers, payers, biotechnology, pharmaceutical and medical equipment manufacturers to increase patient access to advanced cancer care. US Oncology supports one of the nation's foremost cancer treatment and research networks, accelerating the availability and use of evidence-based medicine and shared best practices.

US Oncology Specialty, LP, is US Oncology's VAWD(TM) certified drug distribution center focused on delivering safe and effective oncology drugs to community-based practices. Its ePedigree technology tracks all products from manufacturer to the practice, and back again in case of returns.

OncologyRx Care Advantage, a national oral oncology specialty pharmacy, provides patients with convenient home delivery of oral cancer therapies and the additional support necessary for safe and supervised use of these oral therapy treatments. Last year the specialty pharmacy successfully expanded to a national service offering, bringing access to home delivery of oral drugs and critical patient support to cancer patients in all 50 U.S. states and the territory of Puerto Rico.

The US Oncology Research network is an established community-based research operation specializing in comprehensive Phase I-IV trials and translational Phase I research. Supported by US Oncology, the network has played a pivotal role in 35 cancer therapies approved by the Food and Drug Administration and more than 38,500 patients have participated in clinical trials.

About US Oncology

US Oncology, headquartered in the Houston area, works closely with physicians, payers, biotechnology, pharmaceutical and medical equipment manufacturers to identify and deliver innovative services that enhance patient access to advanced cancer care.

US Oncology uses its expertise to support every aspect of the cancer care delivery system--from drug development to distribution and outcomes measurement--enabling the company to help increase the efficiency and safety of cancer care. According to the company's last quarterly earnings report, US Oncology is affiliated with 1,211 physicians operating in 456 locations, including 94 radiation oncology facilities in 39 states. For more information, visit the company's Web site, www.usoncology.com.

About the National Safety Council

The National Safety Council is a nonprofit, nongovernmental, international public service organization dedicated to protecting life and promoting health. Members of NSC include more than 45,000 businesses, labor organizations, schools, public agencies, private groups and individuals. Founded in 1913, and chartered by the U.S. Congress in 1953, the primary focus of the NSC is preventing injuries in workplaces, in transportation and in homes and communities.


'/>"/>
SOURCE US Oncology, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Genomic Health Announces Multiple Studies on Oncotype DX(TM) Presented at 2007 American Society of Clinical Oncology (ASCO) Breast Cancer Symposium
2. ESMO, Oxford Journals and the Japanese Society of Medical Oncology announce collaboration
3. SuperGen to Highlight Oncology Pipeline Data in Multiple Presentations at the AACR-NCI-EORTC International Conference
4. U.S. Oncology Initiates Complete Phase Ib Trial of Brostallicin Combination Therapy in Advanced Solid Tumors
5. US Oncology to Report 2007 Third Quarter Earnings Results
6. VioQuest to Present Data on Oncology Compounds VQD-002 and Lenocta(TM) at AACR-NCI-EORTC International Meeting
7. Genomic Health Reports Inclusion of Oncotype DX(TM) in American Society of Clinical Oncology Guidelines
8. Varian Medical Systems Ranks First in Overall Service Performance in 2007 Survey of U.S. Radiation Oncology Professionals
9. Accuray Announces Four New Products at Nations Leading Radiation Oncology Meeting
10. Debiopharm and NanoCarrier Sign License and Supply Agreement for Dach-Platin Polymeric Micelle in Oncology
11. National Autism Association and Deirdre Imus Environmental Center for Pediatric Oncology Announce National Greening Your School Initiative
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2017)... ... 2017 , ... Drs. Justin Kolnick, Kara Diamond, Randall Barton, Keith Hope and ... key role this treatment plays in protecting oral health, along with the benefits of ... who need a root canal in White Plains, NY or their second location in ...
(Date:3/27/2017)... ... March 27, 2017 , ... A study by the founder of the ... Sudeep Roy, MD, was recently published in the American Journal of Cosmetic Surgery. “The ... Buckingham and Roy’s study on the use of Electro Lube during the facelift procedure. ...
(Date:3/27/2017)... ... March 27, 2017 , ... Adding to its ... Journal of Medicine and NEJM Journal Watch, announces the release of NEJM ... by a panel of pediatricians from leading medical centers. The content was then ...
(Date:3/27/2017)... ... March 27, 2017 , ... American Veterinarian™, the ... on veterinary medicine, announces the launch of Veterinarian’s Money Digest™, a business and ... April edition of American Veterinarian™. , “We look forward to launching ...
(Date:3/27/2017)... PA (PRWEB) , ... March 27, 2017 , ... ... business simulation -centric training, today announced the launch of a new research ... strategy, having the skills needed to execute that strategy, and the actual success ...
Breaking Medicine News(10 mins):
(Date:3/27/2017)... March 27, 2017  iCAD (Nasdaq: ICAD), an ... and radiation therapy for the early identification and ... Detection received Premarket Approval (PMA) from the U.S. ... is a first-of-its-kind, concurrent-read computer aided detection solution ... latest innovation available on the PowerLook® Breast Health ...
(Date:3/27/2017)... 27, 2017  PhaseRx, Inc. (NASDAQ: PZRX), a ... liver diseases in children, today reported financial results ... December 31, 2016 and provided an update on ... to make progress during the fourth quarter of ... our non-human primate safety study, and with our lead ...
(Date:3/24/2017)... PUNE, India , March 24, 2017 Abdominal Aortic ... reach $2,614 million by 2022, Globally, registering a CAGR of 5.1% from 2016 to ... and is projected to dominate the market during the study period. ... ... ...
Breaking Medicine Technology: